Evidence map›Paper›PMID 30637562›Full record

ReviewEndocrine2019

F18-choline/C11-choline PET/CT thyroid incidentalomas.

Francesco Bertagna, Domenico Albano, Luca Giovanella, Raffaele Giubbini, Giorgio Treglia

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Endocrine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06852144 (Ruolo Della PET/TC Nella Valutazione di Patologia Tiroidea in un Centro di Medicina Nucleare ad Alto Volume Diagnostico), which is not on this map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06852144 enrolling by invitationnot on this mapstarted 2024, after this paper: background citation

Ruolo Della PET/TC Nella Valutazione di Patologia Tiroidea in un Centro di Medicina Nucleare ad Alto Volume Diagnostico

TypeobservationalSponsorIRCCS Azienda Ospedaliero-Universitaria di BolognaRan2024 to 2029Enrolled418ConditionsMedullary Thyroid Carcinoma, Hyperparathyroidism, Parathyroid CarcinomaArmsclinical practice drug treatment
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. The dilemma ofEndocrine · 2021
    Pooled it
  3. Article
  4. Review
  5. Prevalence of Brain Incidental Lesions Detected byMedicina (Kaunas, Lithuania) · 2022
    Article
  6. Unusual uptakes onQuantitative imaging in medicine and surgery · 2021
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Francesco BertagnaNuclear Medicine, University of Brescia and Spedali Civili di Brescia, Brescia, Italy. francesco.bertagna@unibs.it.
Domenico AlbanoNuclear Medicine, University of Brescia and Spedali Civili di Brescia, Brescia, Italy.
Luca GiovanellaDepartment of Nuclear Medicine and PET/CT Center, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Raffaele GiubbiniNuclear Medicine, University of Brescia and Spedali Civili di Brescia, Brescia, Italy.
Giorgio TregliaDepartment of Nuclear Medicine and PET/CT Center, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThyroid incidentaloma is defined as a thyroid lesion incidentally and newly detected by imaging techniques performed for an unrelated purpose and especially for a non-thyroid disease. Aim of this review is to evaluate the prevalence and clinical significance of focal incidental radiolabelled choline uptake in the thyroid gland (CTI) revealed by PET or PET/CT.

methodsA comprehensive computer literature search of the PubMed/MEDLINE, Scopus, and Embase databases was conducted to find relevant published articles about the prevalence and clinical significance of CTIs detected by PET or PET/CT in patients studied for other oncologic purposes.

resultsFifteen articles (14 case reports, one retrospective study on a larger population sample) were included in the systematic review. Considering the case reports, 7/14 CTIs were benign and 7/14 malignant. In the retrospective study on a larger population sample, 14/15 CTIs which underwent further investigations were benign.

conclusionDespite very rare but probably underestimated, CTIs frequently signal in the presence of unexpected lesions in the thyroid that differ from the indicated reason for which the patient was initially scanned, and the risk of malignancy is not negligible.

Indexed as

Fluorodeoxyglucose F18HumansIncidental FindingsPositron Emission Tomography Computed TomographyThyroid GlandThyroid NeoplasmsFluorodeoxyglucose F18CholineIncidentalPET/CTPositron emission tomographyThyroidThyroid incidentaloma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.